Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Study of the Levofloxacin-Based and Clarithromycin-Based Triple Therapy in First-Line Treatment for Helicobacter Pylori Eradication and Change of Gut Flora and Drug Susceptibility Before and After Treatment

NCT00816140 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT00816140
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00816140 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Study of the Levofloxacin-Based and Clarithromycin-Based Triple Therapy in First-Line Treatment for Helicobacter Pylori Eradication and Change of Gut Flora and Drug Susceptibility Before and After Treatment
Lead sponsor
National Taiwan University Hospital
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2007
Completion date
July 31, 2009
Enrollment
432 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

helicobacter infections